Previous Article | Next Article 
Journal of Clinical Microbiology, July 2005, p. 3309-3313, Vol. 43, No. 7
0095-1137/05/$08.00+0 doi:10.1128/JCM.43.7.3309-3313.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Countrywide Spread of Community- and Hospital-Acquired Extended-Spectrum ß-Lactamase (CTX-M-15)-Producing Enterobacteriaceae in Lebanon
Carole Moubareck,1
Ziad Daoud,2
Noha I. Hakimé,2
Monzer Hamzé,3
Nicole Mangeney,1
Hiam Matta,4
Jacques E. Mokhbat,5
Raymond Rohban,6
Dolla Karam Sarkis,7 and
Florence Doucet-Populaire1,8*
Laboratoire de Microbiologie, Faculté des Sciences Pharmaceutiques et Biologiques, Université Paris 5-René Descartes, Paris, France,1
Saint George Hospital, and University of Balamand, Beirut, Lebanon,2
Lebanese University, Beirut, and Nini Hospital, Tripoli, Lebanon,3
Arz Hospital, Al Metn, Lebanon,4
Rizk Hospital, Beirut, Lebanon,5
Saint Joseph Hospital, Beirut, Lebanon,6
Hôtel Dieu de France Hospital, Beirut, Lebanon,7
C. H. de Versailles, Le Chesnay, France8
Received 17 January 2005/
Returned for modification 25 February 2005/
Accepted 4 April 2005
A prospective study was carried out to assess the extent of carriage of extended-spectrum ß-lactamase (ESBL)-producing Enterobacteriaceae at both hospital and community levels in Lebanon. A total of 1,442 fecal samples were collected from hospital-based patients and 58 from health care workers of six Lebanese tertiary care general hospitals located in different areas of Lebanon between January and March 2003. A total of 382 fecal samples were also collected from healthy subjects between April and June 2003. The samples analysis led to the identification of 118 strains as ESBL producers based on the synergistic effects between clavulanate and selected ß-lactams (ceftazidime and cefotaxime). These strains were isolated from 72 subjects: 61 patients, 2 health care workers, and 9 healthy subjects. One representative strain per subject was selected, and a total of 72 nonduplicate ESBL producers, including a high majority of Escherichia coli (n = 56), Klebsiella pneumoniae (n = 9), Enterobacter cloacae (n = 6), and Citrobacter freundii (n = 1), were characterized. The molecular analysis revealed that the majority of the strains (83%) express CTX-M-15 ESBL (pI 8.6). SHV-5a ESBL (pI 8.2) was produced by 18% of the strains. DNA macrorestriction analysis of ESBL-producing E. coli presented 38 different genotypes, revealing the absence of clonal link among these strains. In addition to the fact that the present study highlights the emergence and the countrywide dissemination of CTX-M-15-producing E. coli in Lebanon, it represents the first report of an SHV-5a-producing C. freundii.
* Corresponding author. Mailing address: Faculté des Sciences Pharmaceutiques et Biologiques, Laboratoire de Microbiologie, 4 Av. de l'Observatoire, 75270 Paris Cedex 06, France. Phone: (33) 1-53-73-99-13. Fax: (33) 1-53-73-99-23. E-mail: florence.doucet-populaire{at}univ-paris5.fr.
Journal of Clinical Microbiology, July 2005, p. 3309-3313, Vol. 43, No. 7
0095-1137/05/$08.00+0 doi:10.1128/JCM.43.7.3309-3313.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Rodriguez-Bano, J., Lopez-Cerero, L., Navarro, M. D., de Alba, P. D., Pascual, A.
(2008). Faecal carriage of extended-spectrum {beta}-lactamase-producing Escherichia coli: prevalence, risk factors and molecular epidemiology. J Antimicrob Chemother
62: 1142-1149
[Abstract]
[Full Text]
-
Nicolas-Chanoine, M.-H., Blanco, J., Leflon-Guibout, V., Demarty, R., Alonso, M. P., Canica, M. M., Park, Y.-J., Lavigne, J.-P., Pitout, J., Johnson, J. R.
(2008). Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J Antimicrob Chemother
61: 273-281
[Abstract]
[Full Text]
-
Mendonca, N., Leitao, J., Manageiro, V., Ferreira, E., the Antimicrobial Resistance Surveillance Program, , Canica, M.
(2007). Spread of Extended-Spectrum {beta}-Lactamase CTX-M-Producing Escherichia coli Clinical Isolates in Community and Nosocomial Environments in Portugal. Antimicrob. Agents Chemother.
51: 1946-1955
[Abstract]
[Full Text]
-
Lavigne, J.-P., Marchandin, H., Delmas, J., Moreau, J., Bouziges, N., Lecaillon, E., Cavalie, L., Jean-Pierre, H., Bonnet, R., Sotto, A.
(2007). CTX-M {beta}-Lactamase-Producing Escherichia coli in French Hospitals: Prevalence, Molecular Epidemiology, and Risk Factors. J. Clin. Microbiol.
45: 620-626
[Abstract]
[Full Text]
-
Lavigne, J.-P., Marchandin, H., Delmas, J., Bouziges, N., Lecaillon, E., Cavalie, L., Jean-Pierre, H., Bonnet, R., Sotto, A.
(2006). qnrA in CTX-M-Producing Escherichia coli Isolates from France. Antimicrob. Agents Chemother.
50: 4224-4228
[Abstract]
[Full Text]
-
Ramdani-Bouguessa, N., Mendonca, N., Leitao, J., Ferreira, E., Tazir, M., Canica, M.
(2006). CTX-M-3 and CTX-M-15 Extended-Spectrum {beta}-Lactamases in Isolates of Escherichia coli from a Hospital in Algiers, Algeria. J. Clin. Microbiol.
44: 4584-4586
[Abstract]
[Full Text]
-
Machado, E., Coque, T. M., Canton, R., Baquero, F., Sousa, J. C., Peixe, L., The Portuguese Resistance Study Group,
(2006). Dissemination in Portugal of CTX-M-15-, OXA-1-, and TEM-1-Producing Enterobacteriaceae Strains Containing the aac(6')-Ib-cr Gene, Which Encodes an Aminoglycoside- and Fluoroquinolone-Modifying Enzyme.. Antimicrob. Agents Chemother.
50: 3220-3221
[Full Text]
-
Oteo, J., Navarro, C., Cercenado, E., Delgado-Iribarren, A., Wilhelmi, I., Orden, B., Garcia, C., Miguelanez, S., Perez-Vazquez, M., Garcia-Cobos, S., Aracil, B., Bautista, V., Campos, J.
(2006). Spread of Escherichia coli Strains with High-Level Cefotaxime and Ceftazidime Resistance between the Community, Long-Term Care Facilities, and Hospital Institutions.. J. Clin. Microbiol.
44: 2359-2366
[Abstract]
[Full Text]
Copyright © 2005 by the American Society for Microbiology. All rights reserved.